Literature DB >> 14715916

Hyperinsulinism in infancy: from basic science to clinical disease.

Mark J Dunne1, Karen E Cosgrove, Ruth M Shepherd, Albert Aynsley-Green, Keith J Lindley.   

Abstract

Ion channelopathies have now been described in many well-characterized cell types including neurons, myocytes, epithelial cells, and endocrine cells. However, in only a few cases has the relationship between altered ion channel function, cell biology, and clinical disease been defined. Hyperinsulinism in infancy (HI) is a rare, potentially lethal condition of the newborn and early childhood. The causes of HI are varied and numerous, but in almost all cases they share a common target protein, the ATP-sensitive K+ channel. From gene defects in ion channel subunits to defects in beta-cell metabolism and anaplerosis, this review describes the relationship between pathogenesis and clinical medicine. Until recently, HI was generally considered an orphan disease, but as parallel defects in ion channels, enzymes, and metabolic pathways also give rise to diabetes and impaired insulin release, the HI paradigm has wider implications for more common disorders of the endocrine pancreas and the molecular physiology of ion transport.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715916     DOI: 10.1152/physrev.00022.2003

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  84 in total

Review 1.  Pulmonary Hypertension and ATP-Sensitive Potassium Channels.

Authors:  Conor McClenaghan; Kel Vin Woo; Colin G Nichols
Journal:  Hypertension       Date:  2019-05-28       Impact factor: 10.190

2.  Functional analysis of a structural model of the ATP-binding site of the KATP channel Kir6.2 subunit.

Authors:  Jennifer F Antcliff; Shozeb Haider; Peter Proks; Mark S P Sansom; Frances M Ashcroft
Journal:  EMBO J       Date:  2005-01-13       Impact factor: 11.598

Review 3.  ATP-sensitive potassium channelopathies: focus on insulin secretion.

Authors:  Frances M Ashcroft
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

4.  Intracellular ATP-sensitive K+ channels in mouse pancreatic beta cells: against a role in organelle cation homeostasis.

Authors:  A Varadi; A Grant; M McCormack; T Nicolson; M Magistri; K J Mitchell; A P Halestrap; H Yuan; B Schwappach; G A Rutter
Journal:  Diabetologia       Date:  2006-05-12       Impact factor: 10.122

Review 5.  K(ATP) channel pharmacogenomics: from bench to bedside.

Authors:  S Sattiraju; S Reyes; G C Kane; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2007-10-24       Impact factor: 6.875

6.  Mutations in KCNJ11 are associated with the development of autosomal dominant, early-onset type 2 diabetes.

Authors:  Limei Liu; Kazuaki Nagashima; Takao Yasuda; Yanjun Liu; Hai-Rong Hu; Guang He; Bo Feng; Mingming Zhao; Langen Zhuang; Taishan Zheng; Theodore C Friedman; Kunsan Xiang
Journal:  Diabetologia       Date:  2013-09-10       Impact factor: 10.122

7.  Activation of the Na+/K+-ATPase by insulin and glucose as a putative negative feedback mechanism in pancreatic beta-cells.

Authors:  M Düfer; D Haspel; P Krippeit-Drews; L Aguilar-Bryan; J Bryan; G Drews
Journal:  Pflugers Arch       Date:  2008-10-03       Impact factor: 3.657

8.  Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents.

Authors:  Domenico Tricò; Andrea Natali; Silva Arslanian; Andrea Mari; Ele Ferrannini
Journal:  JCI Insight       Date:  2018-12-20

9.  Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue.

Authors:  Fei-Fei Yan; Yu-Wen Lin; Courtney MacMullen; Arupa Ganguly; Charles A Stanley; Show-Ling Shyng
Journal:  Diabetes       Date:  2007-06-15       Impact factor: 9.461

Review 10.  Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator.

Authors:  Jussi Aittoniemi; Constantina Fotinou; Tim J Craig; Heidi de Wet; Peter Proks; Frances M Ashcroft
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-27       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.